A 3‐miRNA signature predicts survival of patients with hypopharyngeal squamous cell carcinoma after post‐operative radiotherapy

Since the prognosis of hypopharyngeal squamous cell carcinoma (HSCC) remains poor, identification of miRNA as a potential prognostic biomarker for HSCC may help improve personalized therapy. In the 2 cohorts with a total of 511 patients with HSCC (discovery: N = 372 and validation: N = 139) after po...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xinbo, Lu, Zhongming, Gross, Neil, Li, Guojun, Zhang, Fenghua, Lei, Dapeng, Pan, Xinliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850940/
https://www.ncbi.nlm.nih.gov/pubmed/31578816
http://dx.doi.org/10.1111/jcmm.14702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850940/
https://www.ncbi.nlm.nih.gov/pubmed/31578816
http://dx.doi.org/10.1111/jcmm.14702

Ejemplares similares